macro

RBC Capital cuts price targets on Zillow and Marvell, keeps Outperform

RBC Capital keeps Outperform ratings on Zillow and Marvell but cuts their price targets by 18.2% and 41.2%, per TradingView data.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

RBC Capital kept its Outperform rating on Zillow Group and lowered its price target from $55 to $45, a cut of 18.2%. According to TradingView, the new target implies a 39.1% gain from the November 2 close of $32.34.

On the same day, RBC Capital kept its Outperform rating on Marvell Technology but reduced its target from $425 to $250, a 41.2% decrease. The target implies a 45.8% gain from the November 2 close of $171.41.

Other brokers' recent notes over the past 30 days put Zillow targets between $31 and $48, and Marvell targets between $225 and $300.

why it matters

Revisions from a single broker mainly matter to holders of these stocks, but they are a local signal for the broader market. The spread on Marvell stands out: RBC Capital's new target sits below the $300 levels held by Susquehanna and Needham.

tags

instruments

Zillow GroupMarvell Technology

sources

  1. RBC Capital maintains Zillow Group at Outperform, lowers price target to $45 from $55 — TradingView, 3 November 2026 at 14:46 UTC
  2. RBC Capital maintains Marvell Technology at Outperform, lowers price target to $250 from $425 — TradingView, 3 November 2026 at 14:45 UTC
  3. RBC Capital maintains Krystal Biotech at Outperform, lowers price target to $375 from $400 — TradingView, 3 November 2026 at 15:01 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗